메뉴 건너뛰기




Volumn , Issue , 2016, Pages 309-330

Reversible glucocorticoid esterification

Author keywords

[No Author keywords available]

Indexed keywords


EID: 0242689373     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.3109/9780203908532-15     Document Type: Chapter
Times cited : (3)

References (10)
  • 1
    • 1842292795 scopus 로고    scopus 로고
    • Pharmacokinetic/pharmacodynamic aspects of aerosol therapy using glucocorticoids as a model
    • Hochhaus G, Möllmann H, Derendorf H, Gonzalez-Rothi RJ. Pharmacokinetic/pharmacodynamic aspects of aerosol therapy using glucocorticoids as a model. J Clin Pharmacol 1997; 37(10):881-892.
    • (1997) J Clin Pharmacol , vol.37 , Issue.10 , pp. 881-892
    • Hochhaus, G.1    Möllmann, H.2    Derendorf, H.3    Gonzalez-Rothi, R.J.4
  • 2
    • 0024534284 scopus 로고
    • Pulmonary disposition of the potent glucocorticoid budesonide, evaluated in an isolated perfused rat lung model
    • Ryrfeldt Å, Persson G, Nilsson E. Pulmonary disposition of the potent glucocorticoid budesonide, evaluated in an isolated perfused rat lung model. Biochem Pharmacol 1989; 38:17-22.
    • (1989) Biochem Pharmacol , vol.38 , pp. 17-22
    • Å, R.1    Persson, G.2    Nilsson, E.3
  • 3
    • 0016228157 scopus 로고
    • Absorption of corticosteroids from the rat lung
    • Burton J, Schanker L. Absorption of corticosteroids from the rat lung. Steroids 1974; 23:617-624.
    • (1974) Steroids , vol.23 , pp. 617-624
    • Burton, J.1    Schanker, L.2
  • 4
    • 0000419721 scopus 로고
    • Dissolution, tissue binding and kinetics of receptor binding of inhaled glucocorticoids
    • Högger P, Rawert I, Rohdewald P. Dissolution, tissue binding and kinetics of receptor binding of inhaled glucocorticoids. Eur Respir J 1993; 6(suppl 17):584s.
    • (1993) Eur Respir J , vol.6 , pp. 584
    • Högger, P.1    Rawert, I.2    Rohdewald, P.3
  • 5
    • 0033504116 scopus 로고    scopus 로고
    • Inhaled corticosteroid therapy in newly detected mild asthma
    • O’Byrne PM. Inhaled corticosteroid therapy in newly detected mild asthma. Drugs 1999; 58(suppl 4): 17-24.
    • (1999) Drugs , vol.58 , pp. 17-24
    • O’Byrne, P.M.1
  • 8
    • 0002007345 scopus 로고    scopus 로고
    • Modes to achieve topical selectivity of inhaled glucocorticosteroids-focus on budesonide
    • South Carolina, May 3-7
    • Edsbäcker S, Jendbro M. Modes to achieve topical selectivity of inhaled glucocorticosteroids-focus on budesonide. Proceedings of Respiratory Drug Delivery VI, South Carolina, May 3-7, 1998, pp. 71-82.
    • (1998) Proceedings of Respiratory Drug Delivery VI , pp. 71-82
    • Edsbäcker, S.1    Jendbro, M.2
  • 9
    • 0035042689 scopus 로고    scopus 로고
    • Pharmacokinetics of budesonide and its major ester metabolite after inhalation and intravenous administration of budesonide in the rat
    • Jendbro M, Johansson C-J, Strandberg P, Falk-Nilsson H, Edsbäcker S. Pharmacokinetics of budesonide and its major ester metabolite after inhalation and intravenous administration of budesonide in the rat. Drug Metab Disp 2001; 29:769-776.
    • (2001) Drug Metab Disp , vol.29 , pp. 769-776
    • Jendbro, M.1    Johansson, C.-J.2    Strandberg, P.3    Falk-Nilsson, H.4    Edsbäcker, S.5
  • 10
    • 0027275566 scopus 로고
    • Physiological parameters in laboratory animals and in humans
    • Davies B, Morris T. Physiological parameters in laboratory animals and in humans. Pharmaceut Res 1993; 10(7): 1093-1095.
    • (1993) Pharmaceut Res , vol.10 , Issue.7 , pp. 1093-1095
    • Davies, B.1    Morris, T.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.